EUCTR2005-002252-18-IT进行中（未招募）不适用
Hypotonic efficacy and tollerability of Travoprost in patient with glaucoma or ocular hypertension, monotherapy or fixed association beta-blocking not controlled or intollerant.
ALCON ITALIA0 个研究点目标入组 300 人开始时间: 2005年11月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Hypotonic efficacy and tollerability of Travoprost in patient with openangle primary glaucoma and/or ocular hypertension, not controlled withdorzolamide + timolol treatment in fixed association, or intollerantto itReducing high intraocular pressure in patient with ocular hypertension or open-angle glaucomaMedDRA version: 6.1Level: PTClassification code 10030348EUCTR2005-001786-34-ITALCON ITALIA80
招募中
不适用
Efficacy IOP lowering and safety of Travoprost Ophthalmic Solution in Normal Tension Glaucoma patients.GlaucomaJPRN-UMIN000007026I.CHANGE study group100
招募中
不适用
Assessing the efficacy of changing to Travoprost/Timolol fixed combination, as replacement therapy in patients on prostaglandin monotherapyGlaucomaJPRN-UMIN000007028I.CHANGE study group180
尚未招募
Unknown
Effect of preservative free travoprost on proximal tear drainage system using scan machine- a clinical studyCTRI/2023/04/051290Sankara eye hospital Shimoga .
已完成
不适用
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma or Ocular Hypertensio-H40H40PER-028-02ALCON RESEARCH LTD.,